bioCSL donates 700,000 influenza vaccines to Partnership for Influenza Vaccine Introduction

bioCSL, Inc., said on Monday that it will donate more than 700,000 vaccines to the Partnership for Influenza Vaccine Introduction, which helps low- and middle-income countries expand vaccination programs and reduce illness and flu-related death.

The Partnership is led by the U.S. Centers for Disease Control and Prevention and the Task Force for Global Health (TFGH).

"Influenza is a common viral infection that can sometimes result in serious complications," bioCSL President Marie Mazur said. "For this reason, it is critical that influenza vaccine is made available to everyone - especially in areas of the world where robust healthcare systems are not in place to facilitate the acquisition and distribution of vaccine. The Partnership is actively addressing this need on a large scale, and we at bioCSL are pleased to be partnering in this effort for the second year in a row by making a significant donation of our vaccine."

The Partnership began in 2011, and won the CDC Director's Award for Innovation. The program has continued to expand.

"This year's vaccination campaign in Laos would not be possible without the flu vaccine donations provided by private organizations," Chief of the Epidemiology and Prevention Branch of the CDC's Influenza Division Joseph Bresee said. "Private donors' contributions allow eligible countries to establish and expand their own annual influenza vaccination programs with guidance from CDC, Task Force for Global Health, World Health Organization and other public health partners. In short, vaccine donations are absolutely critical to the mission."